<?php
/* @var $this SiteController */

$this->pageTitle= 'Board of Advisors | ' . Yii::app()->name;
$this->breadcrumbs=array(
	'Board of Advisors',
);
?>
<div class="big-container">
	<section class="breadcrumb-section">
		<div class="container">
		</div>
	</section>
	<section class="leadership-summary">
		<div class="container">
			<div class="row">
				<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
					<h5 class="leadership-title">Board of Advisors</h5><br />
				</div>
			</div>
			<div class="row">
				<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
					<h6 class="leadership-title">Donald Reynolds</h6>
					<p class="leadership-body">Don practices in the areas of capital markets, securities law, mergers & acquisitions, 
					venture capital and corporate law. He joined the firm in 1993, prior to which he practiced at Wilson, Sonsini, 
					Goodrich & Rosati, the largest law firm in Silicon Valley. Donâ€™s experience ranges from representing start-up 
					companies in their initial organizations and financings, to representing companies and underwriters in public 
					<br />
					offerings, mergers & acquisitions, and SEC reporting and compliance matters. Don has worked on over fifty public offerings.  
					Don has served as counsel to Pharmaceutical Product Development (PPD) as well as several other biotechnology companies 
					in the Research Triangle Park.  Don also is a frequent speaker on the JOBS act.
					<br/>Don teaches Securities Regulation at Campbell University's law school. He chaired the NCBA Securities Regulation Committee
					 from 1997 through 2001, and was on the NCBA Business Council from 2000 through 2003. 
					 Don is the only Securities & Corporate Finance attorney outside Charlotte to have been listed in 
					 North Carolina Super Lawyers, garnering that honor each year since 2007.  
					 Don received his B.A. from Whitman College and his J.D. from New York University School of Law.</p><br />
				</div>
			</div>
			<div class="row">
				<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
					<h6 class="leadership-title">Simon Pedder, PhD</h6>
					<p class="leadership-body">Dr. Simon Pedder, Ph.D. founded and served as the Chief Executive Officer and President of 
					Chelsea Therapeutics International Ltd. from May 2004 until July, 2012. In that capacity Dr. Pedder took Chelsea public 
					and raised over $250 million.  Previously Dr. Pedder served as Global Vice President of Pharmaceutical Business, 
					Oncology at Hoffmann-La Roche Inc. and as an Executive Officer.  He has served as Director of Pharmaceutical Business, 
					Pharmaceutical Development and Project Management. At Hoffmann-La Roche, he was in charge of the development of 
					Pegasys and Copegus, which have become the standard of care for the treatment of Hepatitis C and B and have combined 
					annual worldwide sales of over $1.8 billon.  Dr. Pedder holds a Ph.D. in Pharmacology from the College of Medicine at 
					the University of Saskatchewan and his undergraduate from the University of Waterloo in Canada.</p><br />
				</div>
			</div>
		</div>
	</section>
	<section class="leadership-2column">
		<div class="container">
			<div class="row">
				<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
				</div>
				<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
				</div>
			</div>
		</div>
	</section>
</div>